Literature DB >> 8212302

Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation.

R J Stratta1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212302

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

Authors:  F Brown; L Banken; K Saywell; I Arum
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

4.  Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR.

Authors:  S W Muir; J Murray; M A Farquharson; D J Wheatley; A R McPhaden
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 5.  Viral prophylaxis in organ transplant patients.

Authors:  Michelle Slifkin; Shira Doron; David R Snydman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.

Authors:  C Y Tong; L Cuevas; H Williams; A Bakran
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 7.  Cytomegalovirus infection in solid organ transplantation: economic implications.

Authors:  Ananya Das
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 8.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

9.  Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?

Authors:  Maryam Mozaffar; Shahrzad Shahidi; Marjan Mansourian; Shirinsadat Badri
Journal:  J Transplant       Date:  2018-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.